Brenda Messer
Nurse Practitioner · Kansas City, MONPI 1356820179
Payments from drug & device makers
Across 130 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$326
- AbbVie$220
- Gilead$149
- Novartis$143
- AVEO Pharmaceuticals, Inc.$132
- Merck$132
- plus $2K from 35 others
What the payments were for
- Food & beverage$2,46294%
- Education$1616%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $326 |
| AbbVie | 14 | $220 |
| Gilead | 5 | $149 |
| Novartis | 7 | $143 |
| AVEO Pharmaceuticals, Inc. | 3 | $132 |
| Merck | 7 | $132 |
| Johnson & Johnson(2 entities) | 5 | $126 |
| Sanofi | 5 | $102 |
| Seagen Inc. | 2 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $77 |
| Eisai Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Daiichi Sankyo Inc. | 3 | $67 |
| GSK | 3 | $61 |
| Astellas Pharma US Inc | 3 | $58 |
| Incyte Corporation | 3 | $52 |
| Tersera Therapeutics LLC | 2 | $49 |
| Lundbeck LLC | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Bristol Myers Squibb | 3 | $47 |
| Pfizer | 2 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Stemline Therapeutics Inc. | 2 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $30 |
| Bayer | 2 | $29 |
| Sobi, Inc | 1 | $27 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| Caris MPI, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Array Biopharma Inc | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $14 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$2,623 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 24 | $650 |
| Doxycycline Hyclate | 54 | $437 |
| Ondansetron Hcl | 18 | $421 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 61 | $373 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $372 |
| Cefdinir | 16 | $224 |
| Ondansetron OdtOndansetron | 12 | $213 |
| Fluticasone Propionate | 17 | $180 |
| Methylprednisolone | 28 | $169 |
| Cephalexin | 36 | $119 |
| Triamcinolone Acetonide | 13 | $47 |
| Azithromycin | 11 | $23 |
| Prednisone | 20 | $21 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Kansas City
- Robert HafnerKansas City$47K
- Courtney JefferyKansas City$24K
- Shea FijalKansas City$18K
- Janay KissingerKansas City$14K
- Jennifer PoundKansas City$11K
- Catherine SpellKansas City$10K
- Lakeisha KellyKansas City$10K
- Moeid RiazKansas City$8K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.